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Abstract
AIM: To study gastric mucosal interleukine-8 (IL-8) mRNA 
expression, the cytotoxin-associated gene A (cagA) muta-
tion, and serum pepsinogen (PG) Ⅰ/Ⅱ ratio related risk 
in Thai gastric cancer.
METHODS: There were consent 134 Thai non-cancer 
volunteers who underwent endoscopic narrow band 
imaging examination, and 86 Thais advance gastric 
cancer patients who underwent endoscopic mucosal 
biopsies and gastric surgery. Tissue samples were 
taken by endoscopy with 3 points biopsies. The serum 
PG Ⅰ, Ⅱ, and Helicobacter pylori  (H. pylori ) immu-
noglobulin G (IgG) antibody for H. pylori  were tested 
by enzyme-linked immunosorbent assay technique. 
The histopathology description of gastric cancer and 
non-cancer with H. pylori  detection was defined with 
modified Sydney Score System. Gastric mucosal tissue 
H. pylori  DNA was extracted and genotyped for cagA 
mutation. Tissue IL-8  and cyclooxygenase-2 (COX-2) 
mRNA expression were conducted by real time rela-
tive quantitation polymerase chain reaction. From 17 
Japanese advance gastric cancer and 12 benign gastric 
tissue samples, all were tested for genetic expression 
with same methods as well as Thai gastric mucosal 
tissue samples. The multivariate analysis was used for 
the risk study. Correlation and standardized t -test were 
done for quantitative data, P  value < 0.05 was consid-
ered as a statistically significant.
RESULTS: There is a high non cagA  gene of 86.8 per 
cent in Thai gastric cancer although there are high 
yields of the East Asian type in the positive cagA. The 
H. pylori  infection prevalence in this study is reported 
by combined histopathology and H. pylori  IgG antibody 
test with 77.1% and 97.4% of sensitivity and specific-
ity, respectively. The serum PG Ⅰ/Ⅱ ratio in gastric 
cancer is significantly lower than in the non-cancer 
group, P  = 0.045. The serum PG Ⅰ/Ⅱ ratio of less 
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than 3.0 and IL-8 mRNA expression ≥ 100 or log10 ≥ 
2 are significant cut off risk differences between Thai 
cancer and non-cancer, P  = 0.03 and P  < 0.001, re-
spectively. There is a significantly lower PGI/II ratio in 
Japanese than that in Thai gastric cancer, P  = 0.026. 
Serum PG Ⅰ/Ⅱ ratio at cut off less than 3.0 and IL-8 
mRNA expression Raw RQ > 100 or log10 > 2 are sig-
nificantly difference between Thai cancer group when 
compared to non-cancer group, P  = 0.013 and P  < 
0.001, respectively. In the correlation study, low PG Ⅰ/
Ⅱ ratio does not associate with chronic atrophic gastri-
tis severity score in Thais non-cancer cases. However, 
there is a trend, but not significant convert correlation 
between IL-8 mRNA expression level and low PG Ⅰ/Ⅱ 
ratio in Thai positive H. pylori  infection. The high ex-
pression of IL-8 gene demonstrates a poorer prognosis 
by stage and histology.
CONCLUSION:Predominant gastric mucosal IL-8 mRNA 
expression level, H. pylori  infection, and low PG Ⅰ/Ⅱ 
ratio are relative risks for Thai gastric cancer without 
correlation with cagA mutation.
© 2013 Baishideng. All rights reserved.
Key words: Gastric cancer; CagA mutation; Interleukine-8 
mRNA expression; Helicobacter pylori ; Pepsinogen Ⅰ/Ⅱ 
ratio
Core tip: A high level of interleukine-8 (IL-8) mRNA ex-
pression was detected in more than eighty percent of 
Thai gastric cancer patients and nearly two fold in the 
normal Thai population. The majority of Northern Thai 
gastric cancer patients who had negative cagA  gene 
Helicobacter pylori infection even with or without its 
mutation, still have a high IL-8 mRNA expression level. 
The pathogenesis of Thai gastric cancer may primarily 
involve another gate-way besides the bacterial factor. 
The results show that there is a predominantly cancer 
inflammation state regulated by IL-8 mRNA expression 
level that can be detected in Thai gastric cancer pa-
tients.
Yamada S, Kato S, Matsuhisa T, Makonkawkeyoon L, Yoshida M, 
Chakrabandhu T, Lertprasertsuk N, Suttharat P, Chakrabandhu 
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IL-8 mRNA expression in non-cagA Thais is risk for gastric 
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INTRODUCTION
Gastric cancer pathogenesis is a well-known worldwide 
multifactorial condition. The gastric cancer incidence 
rate in Thailand ranks ninth by 4.1:100000 in males and 
2.1:100000 in females. Despite being a low incidence 
country, northern Thailand has a higher gastric cancer in-
cidence rate with 6.6:100000 in males that ranks fifth of  
overall cancer in the Northern Thai region, and 4.5:100000 
in females[1]. The author was interested in the carcinogen-
esis of  gastric cancer in Thais, and why the incidence in 
Thais is much different from other East Asian countries. 
The interleukin-8 (IL-8) gene is one of  the principal me-
diators for the inflammatory response gate way that was 
first reported in 1970s, and it is one of  factors that are 
possible to affect gastric cancer carcinogenesis[2]. A recent 
case-controlled surveillance study in northern Thailand 
on cytokine gene IL-1b-511 mutations in three East Asian 
populations showed no predominantly correlated specific 
causative factor responsible for differences among ethnics 
and histologic types[3,4]. Therefore, the author proposed 
the study on other gate-ways of  cytokine expression in 
the human gastric mucosal cell.
Recently, an in vitro study showed the association of  
the mucosal tissue IL-8 mRNA expression related to the 
Helicobacter pylori (H. pylori), positivity cytotoxin-associated 
gene A (cagA) gene. The East Asian genotype was report-
ed in Japanese gastric cancer in about 85% of  the cases. 
Many in vitro studies showed this toxicity gene related to 
gastric mucosal cell injury, inflammation, and oncogenic 
potential[5-7]. The cagA, East Asian genotype is commonly 
detected in chronic gastritis and gastric cancer of  the Japa-
nese[8,9]. There is reported data that a low serum pepsino-
gen (PG) Ⅰ/Ⅱ ratio of  less than 3.0 with a PG Ⅰ level of  
less than 70 ng/dL was considered as a high risk factor 
for Japanese gastric cancer[10,11]. There is no recent in vivo 
study reporting a correlation among these above factors, 
especially IL-8 and cyclooxygenase-2 (COX-2) mRNA ex-
pression level in Thais.
The author hypothesized that gastric mucosal tissue 
IL-8 mRNA expression may be different among ethnici-
ties, and it may correlate to other reference pathogenesis 
factors. This study aimed to look for the risk and correla-
tion of  these factors in Thai gastric cancer. The level of  
IL-8, COX-2 mRNA expression, and cagA gene mutation 
distribution were also to be the first report in Thai gastric 
cancer.
MATERIALS AND METHODS
Research methodology was considered and permitted by 
Thai and Japanese local ethical committees, the NRCT 
and Japan Society for the Promotion of  Science code 
ID-NRCT 10726.
Patient characteristics and volunteer selection
An experimental based cross-sectional study was con-
ducted in the Gastrointestinal Surgery and Endoscopy 
Unit, Chiang Mai University Hospital from 2007 through 
2010. Informed consents were obtained from 86 Thai 
gastric cancer patients who underwent narrow band im-
aging (NBI) endoscopy and gastric surgery during year 
2007-2010, and 134 Thai non-cancer volunteers who 
underwent NBI endoscopic examination from 2006 to 
2008. All gastric cancer patients in this study had locally 
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advanced gastric cancer, and underwent examinations by 
endoscopy before curative gastric resection. Seventeen 
advanced stage Japanese gastric cancer and 12 non-cancer 
surveillance patients were recruited. Peptic ulcer disease 
was excluded in this study. Gastric mucosal tissue samples 
were taken by endoscopy with three biopsy sites for pa-
thology and bimolecular genetic tests before surgical treat-
ment. In cancer cases, biopsy points were specified from 
non-necrotic areas of  the tumor. The histopathology 
description of  the tumor and histologic type were de-
fined. For pathological examination in both groups, 
chronic gastritis and metaplasia with H. pylori detection 
were classified with a modified Sydney Score System.
Serum PG Ⅰ and Ⅱ level, and H. pylori immunoglobulin G 
antibody test
A 5 c sample of  venous blood was collected from each 
study participant. The red blood cell and serum separa-
tion was done, and preserved at -20 ℃. The serum PG Ⅰ, 
Ⅱ, and immunoglobulin G (IgG) antibody for H. pylori 
were tested by the standard enzyme-linked immunosor-
bent assay technique. The standard cut off  value used was 
a PG Ⅰ level of  more than 70 ng/mL or PG Ⅰ/Ⅱ ratio 
more than 3.0 for no atrophy or positive Grade 1, PG Ⅰ < 
70 ng/mL and PG Ⅰ/Ⅱ ratio < 3.0 excluding severe 
atrophy for moderate atrophy or positive Grade 2, and 
PG Ⅰ < 30 ng/mL and PG Ⅰ/Ⅱ ratio < 2.0 for severe 
atrophy or positive Grade 3, respectively[10,11]. All samples 
were tested twice for reliability confirmation (Toyobo, co, 
Ltd., Japan)
Tissue H. pylori DNA extraction and cagA genotypting 
method
The tissue H. pylori DNA extracted from the lower antral 
position in the stomach was examined by the polymerase 
chain reaction method, and genotyped for cagA mutation 
in all samples by the author (Samples were also examined 
by double blinded test by Toyobo, co, Ltd). The H. pylori 
positive control of  cagA positive strain number 11638 
(Western), 26695 (Western), and F57 (East Asian) were 
provided by the collaborative institute. The bacterial tis-
sue DNA and genotyping method with primers used 
in this study were conducted as recently described. The 
specific oligonucleotide primers forward (5’-AAAAGC-
GACCTTGAAAATTCC-3’; nucleotides 2299-2319), re-
verse-1 (5’-CTTCATTTTTTTGAGCTTGTTGAGC-3’; 
nucleotides 2488-2463) and reverse-2 (5’-ATTAAT-
GCGTATGTGGCTGTTAGTAGC-3’; nucleotides 
3222-3195, were originally described by Azuma et al[12].
Cell line culture and gastric mucosal total mRNA extraction 
with reverse transcriptase reaction for cDNA synthesis
The AGS cell line was grown before cell collection for 
mRNA extraction at a cell count of  2 × 106-4 × 106. They 
underwent a total mRNA extraction protocol. The tech-
nique followed was a reverse transcriptase reaction using 
a commercial high capacity RNA-to-cDNA kit (Applied 
Biosystems)[13]. 
Gastric mucosal IL-8 and COX-2 mRNA expression by 
relative quantification real time reverse transcription-
polymerase chain reaction
We conducted the experiment from three positions of  
gastric mucosal biopsies in all Thais and Japanese study 
participants. All of  gastric mucosal tissue samples were 
transformed to cDNA after total mRNA extraction. The 
analysis was substantially correctable by analysis both in 
raw relative quantitation (RQ) and log10 value for adjust-
ed normal distribution curve. All Human TaqMan probe 
primer express that was used in this study had 81-base 
pairs (bp) IL-8 specific human primer assay ID number 
Hs99999034_m1, 111- base pairs (bp) COX- 2 assay ID 
number Hs01573471_m1, and 121- base pairs (bp) spe-
cific human glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) Hs99999905_m1 those designed and sup-
plied by Applied Biosystems, United States. The internal 
control was performed by GAPDH of  a matched num-
ber template. The real-time relative quantitation value 
was measured by comparing to the base line value of  
AGS cell line subject control before making the analysis. 
Statistical analysis
A student t-test was used for quantitative data, IL-8 and 
COX-2 mRNA expression level, and PG level. The χ 2 
test was used for qualitative data. The correlation study 
for pair factors was done in subgroup analysis for defined 
groups of  ethnic, cancer and non-cancer populations. The 
multivariate analysis was used for risk study for both non-
normal distribution and normal distribution curve data 
bases. STATA 11.0, United States and SPSS 16, United 
States were used for statistical analysis, and the P value of  
less than 0.05 was considered statistically significant.
RESULTS
There were 86 cases of  advanced gastric cancer and 45 
(33.8%) normal control cases, 46 (34.6%) non-peptic 
disease benign lesions without recent history of  any treat-
ment, and 42 (31.6%) chronic gastritis cases among 134 
non-cancer control cases who were included in the genet-
ic expression experiment. Thai male and female cancer 
incidences are 60.5% (52/86) and 34.0% (39/86), respec-
tively. Males are also the predominant gender in Japanese. 
Both nations have significantly high incidence of  gastric 
cancer at age 40 years old or above.
The H. pylori infection prevalence is reported by com-
bined histopathology, H. pylori IgG antibody level, and 
23S rDNA results that have 77.1% and 97.4% of  sen-
sitivity and specificity, respectively. Among Thai cancer 
patients and non-cancer volunteers, H. pylori prevalence 
was 72.1% and 71.6%, respectively. Meanwhile, Thai gastric 
cancer cases had a cagA genotype demonstrated in only 
7/62 (12.3%) in positive H. pylori infection cases by 23S 
rDNA that yields six cases of  East Asian type and one 
case of  Western type. In non-cancer volunteers, there 
were 62/98 (63.9%) of  positive cagA and 34/98 (36.1%) 
of  negative cagA genotyping in positive H. pylori infec-
Yamada S et al . IL-8  mRNA expression and gastric cancer
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tion cases that yielded 47.7% of  East Asian, 27.4% of  
Western, and 24.9% of  Mixed genotype. For the six year 
follow up of  18 cases of  high grade chronic atrophic 
gastritis (CAG group) in non-cancer Thais who had long 
term H. pylori cagA East Asian type infection, no one has 
developed gastric cancer. 
The enzyme PG results, showed a significantly lower 
PG Ⅰ/Ⅱ ratio with a mean of  3.3 ± 1.7 in gastric can-
cer patients than one in non-cancer volunteers, P = 0.045, 
and of  other CAG, P = 0.002. There is a significantly 
lower PG Ⅰ/Ⅱ ratio in Japanese gastric cancer than in 
Thai gastric cancer, P = 0.026. 
For IL-8 and COX-2 mRNA expression results, 86 
Thai gastric cancers were tested successfully in compari-
son with 134 Thai non-cancer volunteers. The detection 
rates of  IL-8 mRNA expression were 77/86 (89.5%) in 
Thai gastric cancer and 102/134 (74.6%) in Thai non-
cancer volunteers. Thai population characteristic data 
that was examined for IL-8 mRNA expression is dem-
onstrated in Table 1. Serum enzyme PG Ⅰ, Ⅱ level, and 
H. pylori infection status are demonstrated in the cancer 
population and non-cancer volunteers in Thais is dem-
onstrated in Table 2. We found a remarkable number of  
Thai gastric cancers with a negative cagA; therefore, IL-8 
mRNA expression was examined and the cut-off  point 
of  expression value difference is demonstrated in Table 3. 
Serum PG Ⅰ/Ⅱ ratio at cut-off  point of  less than 3.0 
and raw RQ ≥ 100 or log10 ≥ 2 of  IL-8 mRNA expres-
sion level showed the significantly different between the 
Thai gastric cancer group and the non-cancer group, 
P = 0.045 and P < 0.001, respectively. In the multivariate 
analysis application, the four co-factors related to gastric 
cancer risk including IL-8 mRNA expression in Thais 
are shown in Table 4. 
At the same stage of  advanced gastric cancer, the 
mean levels of  IL-8 mRNA expression in Thai cancer 
and Japanese cancer were 9615.65 (log10 = 2.62) and 
1509.11 (log10 = 2.17), respectively, P = 0.014. For gastric 
cancer risk at cut-off  IL-8 expression level by log10 great-
er than two 2 in Thais and Japanese, odds ratio (OR) = 
7.97 (95%CI: 3.75-16.97, P < 0.001) and OR = 4 (95%CI: 
1.29-12.40), respectively. In the non-cancer group, we 
found that the IL-8 mRNA expression level was lower 
than cancer population with a significant difference, 
P < 0.001. The total mean IL-8 mRNA expression in 
non-cancer Thais was 2262 (log10= 1.49) while that in 
Japanese non-cancer was 10.79 (log10 = 0.69), P < 0.001. 
In comparison within the same ethnic group, the mean 
levels of  IL-8 mRNA expression in Thai and Japanese 
cancer were higher than those in non-cancer, P = 0.05 as 
showed in Figure 1.
The COX-2 mRNA expression did not indicate sig-
nificant rising level with detection rate of  65% in Thai 
and Japanese gastric cancer. In comparison with IL-8 
mRNA expression, although the level of  COX-2 mRNA 
expression was slightly higher in gastric cancer than nor-
mal gastric mucosal tissue, there were much lower levels 
than those of  IL-8 mRNA expression.
In the correlation study, low PG Ⅰ/Ⅱ ratio was not 
associated with the CAG severity score in Thai non-can-
cer cases because of  a few number of  CAG in both Thai 
gastric cancer and non-cancer populations in this study. 
There was no significant difference for the IL-8 mRNA 
expression level in cancer between positive and negative 
H. pylori infection. There was no direct correlation of  
IL-8 mRNA expression level and serum IgG levels. In 
subgroup analysis, there was a significant difference of  
higher levels in groups of  poorly differentiated histopa-
thology in comparing both nations. For the diffuse his-
tologic type, the IL-8 mRNA expression level is about 1.5 
times higher than that of  intestinal histologic type with a 
statistically significant difference in Japanese.
Table 1  Characteristics of 220 Thais examined for interleu-
kine-8 mRNA expression  n  (%)
Variable Cancer 
(n  = 86)
Benign 
(n  =134)
Sex 
   Male 52 (60.5) 41 (30.6)
   Female 34 (39.5) 93 (69.4)
Age (yr)
   < 40 5 (5.8) 28 (20.9)
   ≥ 40 81 (94.2)   106 (79.1)
   mean ± SD 56 ± 11.3 48.5 ± 11.2
Alcohol drinking
   No 50 (58.1) 80 (59.7)
   Yes 36 (41.9) 54 (40.3)
Smoking
   No 62 (72.1)   122 (91.0)
   Yes 24 (27.9)     12 (9.0)
Diseases
   Normal - 45 (33.8)
   Benign lesion 
   (polyps, erosion, mild superficial gastritis)
- 46 (34.6)
   Chronic active gastritis - 42 (31.6)
   Cancer     86 (100.0) -
0.69
2.17
1.49
2.62P  = 0.05
P  = 0.05
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Figure 1  Mean interleukine-8 mRNA expression level measurement of rela-
tive quantitation by real-time reverse transcription-polymerase chain reac-
tion study in gastric cancer comparing with non-cancer population both 
Japanese and Thais. In Japanese and Thais, gastric mucosal interleukine-8 
(IL-8) mRNA expression in cancer is higher than in non-cancer with P = 0.05. 
The mean level of IL-8 mRNA expressions in Thai cancer and Japanese cancer 
were 9615.65 (log10 = 2.62) and 1509.11 (log10 = 2.17), respectively, P = 0.014. 
The mean level of IL-8 mRNA expression in non-cancer Thais is 2262 (log10 = 
1.49) while that in non-cancer Japanese is 10.79 (log10 = 0.69), P < 0.001.
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High IL-8 mRNA expression was primarily found in 
the non-cagA Thai gastric cancer population. There was a 
significantly different mean IL-8 mRNA expression level 
between groups of  negative cagA by log10 = 2.46 (± 1.04) 
and positive cagA by log10 = 3.29 (± 1.68) in the Thai gas-
tric cancer group. However, there were few numbers of  
Thai gastric cancers with positive cagA. In other subgroup 
analysis of  18 Thais who had high grade CAG, some level 
of  IL-8 mRNA expression in the 12 Japanese non-cancer 
patients appeared which an equivalently lower level.
Gastric cancer mucosal tissue IL-8 mRNA expression 
in the cancer position had a significantly higher mean lev-
el than its level at the non-cancer background position in 
both Thai and Japanese shown in Figure 2. There was sig-
nificantly different IL-8 mRNA expression level between 
intestinal (favorable) and diffuse (unfavorable) histologic 
cell types. In Thai gastric cancer, the poorly differentiated 
gastric adenocarcinoma and signet ring cell were predom-
inantly found in this study. The log10 IL-8 mRNA mean 
expressions in unfavorable cell type were 2.55 and 2.85 
in Japanese and Thais, respectively, as shown in Table 5. 
There is a significantly higher level of  IL-8 mRNA ex-
pression in diffuse cell type than that in a differentiated 
histologic cell type, P = 0.04. The differentiated histologic 
cell type in Thais has higher expression level than that in 
Japanese with a statistically significant difference, P = 0.013 
The RT-PCR results of  gastric mucosal tissue and AGS 
Table 4  Multivariate risk analysis for Thai gastric cancer
Variable OR 95%CI P  value
Male 4.32 2.06-9.04 < 0.001
H. pylori infection status 0.98 0.96-0.99    0.020
PG Ⅱ/Ⅰ ratio ≤ 3 2.06 0.94-4.47    0.060
IL-8 mRNA expression 7.97 3.75-16.97 < 0.001
OR: Odds ratio; H. pylori: Helicobacter pylori; PG: Pepsinogen; IL-8: Interleu-
kin-8.
Table 5  Comparative means interleukine-8 mRNA expression 
level detection between Thai and Japanese Cancer popula-
tions divided by histopathology  n  (%)
Histopathology Thai 
(n  = 77)
Japanese 
(n  = 17)
P 
value
Diffuse type 55 (71.4)   4 (23.5) 0.011
   mean ± SD 2.85 ± 1.10 2.55 ± 0.52 0.95
Intestinal type 22 (28.6) 13 (76.5)
   mean ± SD 2.52 ± 1.11 1.56 ± 1.06 0.01
1Statistical difference between groups (P = 0.04). IL-8: Interleukin-8.
Variable Cancer
(n  = 86)
Benign
(n  = 134)
P  
value
PG Ⅰ/Ⅱ, (ng/µL), mean ± SD
   Ⅰ 57.39 ± 46 54.86 ± 68.5 0.780
   Ⅱ 19.42 ± 21 15.42 ± 11.7 0.090
PG Ⅰ/Ⅱ ratio
   ≤ 3 28 (39.4) 34 (27.9)  0.0451
   > 3 43 (60.6) 88 (70.1)
H. pylori pathology 
   Negative 31 (36.8) 60 (44.8) 0.001
   Positive 55 (63.2) 74 (55.2)
Serum IgG
   Negative 31 (46.3) 57 (44.2)  0.8201
   Positive 36 (53.7) 72 (55.8)
CagA genotyping in positive 23S rDNA
   Negative 55 (88.7) 62 (64.6) < 0.0011
   Positive   7 (12.3) 34 (35.4)
H. pylori Infection status
   True negative 20 (24.4) 37 (36.0)  0.1201
   True positive 62 (75.6) 96 (64.0)
Table 2  Serum enzyme pepsinogen Ⅰ, Ⅱ level and Helico-
bacter pylori  infection detection results in Thais  n  (%)
1Some numbers are not included in the analysis due to missing labora-
tories entries. The statistical analysis was performed by χ 2 of each factor. 
IgG: Immunoglobulin G; CagA: Cytotoxin-associated gene A; PG: Pep-
sinogen; H. pylori: Helicobacter pylori.
Table 3  Molecular genetic results of cyclooxygenase-2 and 
interleukine-8 mRNA expression in Thais  n  (%)
Variable Cancer 
(n  = 86)
Benign 
(n  = 134)
P 
value
COX2 raw RQ 
   No expression detection   30 (34.90) 43 (53.10) < 0.0011
   Expression detection   56 (65.10) 38 (46.90)
COX2 raw RQ 
   mean ± SD      41.69 ± 4.90       5.37 ± 4.20 < 0.0011
COX2 log10 (N, %)
   mean ± SD        1.62 ± 0.96       0.73 ± 0.62 < 0.0011
IL-8 raw RQ 
   No expression detection     9 (10.47)   32 (25.37)  < 0.001
   Expression detection   77 (89.53) 102 (74.63)
IL-8 raw RQ 
   ≤ 100 or undetected   33 (38.37) 105 (78.36)  < 0.001
   > 100   53 (61.63)   29 (21.64)
   mean ± SD 9615.64 ± 49715.00 2262.29 ± 10454.60  < 0.010
IL-8 log10
   ≤ 2 or undetected   32 (37.21) 105 (78.36)  < 0.001
   > 2   54 (62.79)   29 (21.64)
   mean ± SD        2.62 ± 1.10       1.49 ± 1.20  < 0.010
1Some numbers are not included in the analysis due to missing laboratory 
data. RQ: Relative quantity; COX2: Cyclooxygenase-2; IL-8: Interleukin-8.
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Figure 2  The mean interleukine-8 mRNA expression in Thais divided by his-
tology and cancer position. Middle is the lessor curvature and non-cancer posi-
tion, lower is the antrum, and Upper is the greater curvature. IL-8: Interleukine-8.
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cell line IL-8 mRNA expression were demonstrated in 
Figure 3. and Figure 4. However, there was no significant 
difference of  IL-8 mRNA expression level between posi-
tive and negative H. pylori infection in subgroup analysis 
of  non-cancer background positions.
In summary, IL-8 mRNA expression level is predom-
inantly found, and trend toward an inverted correlation 
to PG Ⅰ/Ⅱ low ratio in Thai gastric cancer patients. 
There is no direct correlation of IL-8 mRNA expression 
level with the cagA gene mutation in Thai gastric cancer.
DISCUSSION
In the present in vivo study, there is a significant risk of  
IL-8 mRNA expression level predominantly found ris-
ing up more than 80% of  Northern-Thai gastric cancer. 
There is significantly higher level of  IL-8 mRNA expres-
sion in poorly differentiated than in well differentiated 
carcinoma in both Thailand and Japan. There is a trend 
of  converted independent correlation with the very low 
PG Ⅰ/Ⅱ ratio in gastric cancer as well as a few numbers 
of  Thai severe CAG, but no direct correlation with posi-
tive H. pylori infection or cagA genotypes. 
Higher level IL-8 mRNA expression in non-cancer 
Thais comparing with non-cancer Japanese demonstrated 
the difference of  gastric mucosal defense and genetic 
expression between the two nations. Thai gastric cancer 
has less background of  CAG. In this study, there is no 
evidence that showed a direct correlation of  IL-8 mRNA 
expression with cagA mutation genotype in H. pylori posi-
tive cases. Predominant IL-8 mRNA expression level re-
sulted in non-atrophic mucosa of  both gastric cancer and 
non-cancer Thais. The result is different from previous in 
vitro or some in vivo studies in high incidence gastric can-
cer countries, such as Japan, China, and South Korea.
In Thai gastric cancer patients, IL-8 mRNA expres-
sion level at the lessor curvature is the most represented 
location. Its predominantly high level may represent rela-
tively vascular invasion as well as major gastric mucosal 
inflammation. However, the area of  gastric antrum in 
Thai gastric cancer patients has less activity than the les-
sor curvature because atrophy occurs more frequently.
Also, a high level of  IL-8 mRNA expression is mat-
ched with the poor prognosis by histopathology cell type 
and tumor stage. Long-term bacterial infection has less 
effect to change the gastric mucosa into CAG. In our 
Figures 3  Basic experiment result on real-time 
reverse transcription-polymerase chain reaction of 
interleukine-8 mRNA expression with AGS, macro-
phage cell line, normal gastric mucosal cell, AGS 
cancer cell line co-culture with two strains of cagA 
Helicobacter pylori, and positive cagA, Thai non-
cancer samples sequences showed on 12 lanes. M: 
Marker.
1         2         3          4       5        6       7         8          9        10       11      12
ΦX174 AGS M-U937 Control AGS+ T-A001**
Cell line Cell line CagA (W1) CagA (W1) CagA (East Asian)
DNA ladder IL-8 β-actin IL-8 β-actin IL-8 β-actin IL-8 β-actin IL-8 IL-8 β-actin
Lane 1 2 3 4 5 6 7 8 9 10 11 12
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Figure 4  Real-time reverse transcription-polyme-
rase chain reaction result of interleukine-8 mRNA 
expression from AGS, negative control, and Thai 
gastric cancer mucosal tissues. The positive results 
of interleukine-8 (IL-8) mRNA expression appeared at 
320 bp band comparing with 300 bp band of marker (M) 
in lane 1.
DNA ladder ΦX174 AGS cell line Negtive control Tissue No. GC001
Lane 1 2 3 4 5 6 7
M IL-8 β-actin IL-8 β-actin IL-8 β-actin
1                 2              3                 4             5                 6                 7
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recent six year followed up study in non-cancer cases 
controlled with positive H. pylori infection and without 
eradication of  500 new non-cancer cases, a few people 
developed severe gastritis and still have a high PG Ⅰ/Ⅱ 
ratio. In this study, the number of  high PG Ⅰ/Ⅱ ratio 
in Thai cancer is still about 45% which is nearly the same 
percentage in our recently published study[4]. 
A few gastric cancer preventive models on natural 
Thai products were reported[14]. There is one study on 
diet consumption in Thais showing a linkage of  gastric 
cancer risk. The factors which were found to be a higher 
risk but not statistically significant were low intake of  
vegetables and fruits (OR = 1.2, 95%CI: 0.74-1.96) and 
Jeaw prik (mainly chilly with Plara broth or pickled fish), 
a kind of  preserved food in North and North-eastern 
regions of  Thailand (OR = 1.2, 95%CI: 0.76-2.01)[15]. 
The consensus of  the Asian Pacific guideline on gastric 
cancer prevention is still debated in some experts’ opin-
ions[16]. H. pylori infection screening in a low risk gastric 
cancer population is not recommended, but serum PG 
may be helpful to screen the high risk population in 
Northern Thailand. We reported its different character-
istics that rely on H. pylori IgG antibody and PG Ⅰ/Ⅱ 
ratio in our cancer populations comparing to the data in 
a Japanese report[17].
The Japanese study primarily reported the relation of  
cagA genotype and a low PG Ⅰ/Ⅱ ratio. Nevertheless, 
approximately half  of  the Thai cancer population dem-
onstrates a low ratio of  PG Ⅰ/Ⅱ similar to the Japa-
nese. There are still a small number of  Thais who had a 
severe atrophy score related to H. pylori infection though 
in the positive cagA Thai population. 
In this study, the negative cagA gene is found in the 
majority of  Thai gastric cancer unlike the Japanese. In 
Thais, the poorly differentiated cell type gastric adeno-
carcinoma occurred mainly in the negative cagA gene 
H. pylori infection, not in Western type cagA. 
There is a small number of  the Thai population who 
had a severe atrophy score of  gastric mucosa found in 
our recent and present collaborative study[18]. Reduction 
of  the fundic gland in chronic gastritis was also related 
to the low level of  PG Ⅰ/Ⅱ ratio in Japanese[19,20]. In 
our recent study of  subgroup analysis on the PG Ⅰ/Ⅱ 
ratios, there was no significant difference between CAG 
and gastric cancer group, P = 0.12. However, the low 
PG Ⅰ/Ⅱ ratio was significantly related to gastric cancer 
when compared to normal population in a recent match-
case control study by OR of  2.3 (95%CI: 1.10-4.80), P 
= 0.025[4]. The tumor location demonstrated locations 
mainly at the upper portion and corpus in both of  our 
studies. In the present study, the author found risk for 
cancer by OR 2.06 (95%CI: 0.94-4.47), P = 0.059 that 
seems to be close to the result of  our recent study. The 
low PG Ⅰ/Ⅱ ratio was not found to be a high percent-
age in Thais unlike in Japanese gastric cancer[9]. 
For other genetic host factors, in one interesting study, 
two of  the four gastric carcinoma cell lines expressed vas-
cular endothelial growth factor (VEGFR-3) mRNA. In 
17 of  36 gastric carcinoma specimens, VEGFR-3-specific 
immune activity was detected in tumor cells. These an-
giogenesis and lymphangiogenesis were also detected in 
VEGF-C-transfected tumors than in control tumors[21]. 
IL-8 mRNA expression is found to be the gate way me-
chanism of  the vascular epithelial growth factor. For 
IL-1 gene, it is a pro-inflammatory cytokine, and the T/T 
genotype of  IL-1β-511 is suspected as the risk factor 
of  both hypochorhydria related H. pylori infection and 
gastric cancer in a case-control population in the United 
States[22]. The author reported that c/c genotype was a 
risk in Japanese, and a lower number of  c/c genotype was 
found as a minor risk related to Thai gastric cancer[4].
Recent in vivo animal models studies showed the ex-
pressions of  IL-8 and COX-2 had linkage to the epitheli-
al cell which was co-infected with H. pylori. However, our 
preliminary study reported that there was no difference 
of  IL-8 mRNA expression level between a cell line which 
was co-infected with H. pylori and the Thai gastric mucosa 
tissues which had positive or negative H. pylori[23,24]. The 
toleration, remarkable host response to cancer inflamma-
tory process, healing of  stomach mucosal turnover rate, 
and re-healing process of  ulcer in Thais may be different 
and caused by host susceptible differences to the viru-
lence bacteria.
The theory regarding inflammatory cytokine’s influ-
ence on cancer development was first contributed by 
Rudolph Virchow around 150 years ago[25]. Many studies 
regarding IL-8 gene expression remarkably found signifi-
cant relation with H. pylori infection and many cag patho-
genicity island both in vitro[26,27] and in some number in 
in vivo study of  Japanese cancer[28,29].  However, no study 
has demonstrated differences of  expression level in the 
individualized host[30].
In this study, Japanese gastric cancer has a lower IL-8 
mRNA expression on average than that in Thai gastric 
cancer patients at the same stage of  disease and H. pylori 
infection status. However, Japanese gastric adenocarci-
noma cases are mostly an intestinal type and infected by 
positive cagA strain H. pylori. In contrast with Northern 
Thai gastric adenocarcinoma cases, they are mostly dif-
fuse histologic cell type, and infected by negative cagA 
strain H. pylori. Therefore, the authors speculate that the 
predominant level of  IL-8 mRNA expression found in 
non-cagA gene H. pylori infection is not directly related 
to atrophic gastritis mucosa in Thai gastric cancer.
Some results in this study are unexpected outcomes 
and different from our recent knowledge of  in vitro and 
in vivo study in Japanese atrophic gastric mucosa which 
almost easily infected by positive cagA H. pylori infection. 
The cagA was also the suspected cause of  the IL-8 gene 
expression rising.
This result in Thais showed that gastric mucosal tissue 
IL-8 mRNA expression has a higher level in the advanced 
stage and poorer differentiated cell type than in favor-
able histology or differentiated cell type. The author was 
suspicious that the less atrophic background of  Thai 
stomach cancer and non-cancer gastric mucosa may be 
caused by non-cagA H. pylori infection. However, the high 
level of  mRNA IL-8 gene expression in Thai gastric can-
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cer cases may be explained by the cancer inflammation 
carcinogenesis that may not be directly related to only 
H. pylori infection in Thais.
The level of  IL-8 mRNA expression in Thai gastric 
cancer or poorly differentiated gastric carcinoma may 
be regulated by other factors besides of  H. pylori infec-
tion. Also, unknowns remain regarding how long IL-8 
mRNA expression has been high before the occurrence 
of  gastric cancer or after becoming a more advanced 
stage. Although the author analyzed the level of  IL-8 and 
COX-2 mRNA expression level in normal mucosa and 
of  advanced gastric cancer, this occurrence could not be 
shown in early gastric cancer. The environmental factors 
and bacterial virulence effect cannot be excluded.
In this study, the signet ring cell type is predomi-
nantly found in Thai gastric cancer population. The poor 
prognostic histological cell type may have different dis-
ease carcinogenesis related to gastric mucosal tissue IL-8 
mRNA high expression level and severity of  the disease. 
The COX-2 mRNA expression level is directly corre-
lated with only the H. pylori infection, and tended to be 
suppressed unlike IL-8 mRNA expression. The author 
supposed that extremely high gastric mucosal IL-8 ex-
pression level may relate to other factors, such as VEGF 
that could not be demonstrated in this study and should 
be explored further.
In conclusion, this present in vivo study shows results 
of  new factual data on predominant gastric mucosal IL-8 
mRNA expression level in Thai gastric mucosal biopsy 
tissues in both non-cancer and gastric cancer volunteers. 
In the present study, the Northern Thai gastric cancer 
population has a high incidence of  signet ring cell by 
the nature of  histologic type. The positive H. pylori may 
be one of  the co-factors, though the host is infected 
with non-cagA gene and still has an extremely high IL-8 
mRNA expression level. This cytokine expression may 
represent the individual host defense in both high and 
low incidence gastric cancer ethnics. The factual results 
in an experimental based study demonstrated how preva-
lence of  the Northern Thai gastric cancer host had active 
co-infection or had been recently infected by non-cagA 
gene H. pylori infection. The IL-8 mRNA expression level 
does not directly correlate to non-cagA H. pylori infec-
tion in Thai gastric cancer. However, there is a trend of  
converted correlation between IL-8 mRNA expression 
and low ratio PG Ⅰ/Ⅱ without statistical significance, 
and it seems to be an independent correlation. By these 
preliminary results, the author expected to do further 
study on IL-8 mRNA expression that may act as one of  
prognostic genetic biomarkers in clinical practice and for 
chemotherapy application in the nearby future. A study 
on the current cancer chemotherapy with Northern Thai 
gastric cancer population is on-going.
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COMMENTS
Background
The incidence of gastric carcinoma is very low although the incidence of Helico-
bacter pylori (H. pylori) seemed not to be low in Thais. However, the Northern 
Thai population still has the highest gastric cancer incidence in Thailand. Cur-
rently, the disease incidence is rising faster than in the past and still the second 
cause of cancer death worldwide. The cause and risk factors for gastric cancer 
carcinogenesis in Thais is unclear especially the risk related with H. pylori infec-
tion or other cofactors.
Research frontiers
Interleukine-8 (IL-8) mRNA expression is a common event found in some 
epithelial malignancies and in gastric adenocarcinoma either due to H. pylori 
caused chronic inflammation or other causes by unrelated carcinogens. It is not 
clear how the level of this expression related to gastric adenocarcinoma. The 
authors demonstrated that the predominant overexpression of IL-8 mRNA could 
be a potential relative risk for gastric adenocarcinoma in Thais and demon-
strated the difference of its level in relationship with the histologic type of gastric 
cancer.
Innovations and breakthroughs
Recent reports have highlighted the importance of cytotoxin-associated gene A 
(cagA) H. pylori infection and its mutation type that is shown predominantly in 
Japanese gastric cancer carcinogenesis. Particularly in the well differentiated 
histologic type, the IL-8 mRNA expression level in the Japanese seems to be 
much lower than in Thais. However, its level in poorly differentiated cell type of 
Thai gastric adenocarcinoma has less atrophic background and a higher level 
of expression than in well differentiated gastric adenocarcinoma. This is the first 
study to report how measurement of IL-8 mRNA expression level demonstrates 
risk in non-cagA H. pylori infection of Thai gastric cancer and the trend of dif-
ferences in carcinogenesis related to H. pylori infection between high and low 
incidence ethnics. Furthermore, their in vivo studies would suggest that the IL-8 
mRNA expression level yields high prevalence detection in gastric adenocarci-
noma and may be a useful tool for gastric cancer prognostic or therapeutic study.
Applications
By understanding different IL-8 mRNA expression levels, this study may repre-
sent a future study with a tissue molecular biomarker for gastric cancer.
Terminology
IL-8 mRNA expression is pro-inflammatory cytokines that is detected in gastric 
epithelial mucosa and gastric cancer cell lines, such as Kato Ⅲ and AGS cells.
Peer review
The authors examined the expression of IL-8 and cyclooxygenase-2 in AGS cell 
line, normal gastric mucosa, gastritis, and gastric adenocarcinoma tissues. It 
revealed that IL-8 mRNA expression predominantly increased in poorly differenti-
ated or signet ring cell gastric adenocarcinoma that showed the trend of a poorer 
prognosis. The expression was not directly correlated to cagA H. pylori infection 
and its mutation type. The results are interesting and may represent a different 
carcinogenesis of Thai gastric cancer in comparison to recent Japanese studies.
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